TAMs are characterized by an M2 phenotype, promoting tumor growth, angiogenesis, and metastasis and suppressing antitumor immune responses through the secretion of anti-inflammatory cytokines and growth factors such as IL-10 and TGF-β [36]. The gene discussed is TGFB1; the disease is neoplasm.